Clinical Trial Update: No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort

View source ↗

Summary

This trial update reports no prognostic or molecular disparity between synchronous and metachronous metastases in differentiated thyroid cancer, based on a Midd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Differentiated Thyroid Cancer | Status: COMPLETED